Immunology Center
The UCSF Pediatric Immunology Center offers comprehensive evaluations and consultations for children and adolescents with problems involving the immune system.
These include chronic and unusual infections, and primary immunodeficiency disorders, such as hypogammaglobulinemia, which can lead to repeated upper respiratory infections, antibody deficiencies, defects in white blood cells (which play a key role in immune function) and additional immune system impairments. We are a designated center of excellence for immunology care in California.
Our outpatient infusion center provides therapy with intravenous immune globulin and other injected medications.
We have extensive experience in diagnosing and caring for babies and children born with severe combined immunodeficiency (SCID). Our center is designated by the California Department of Public Health to perform screening tests for SCID in newborns, and we can rapidly evaluate babies with abnormal test results. We're also a Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiency, one of 125 in the country that receive funding from the Jeffrey Modell Foundation.
Our locations (1)
Our team
-
Alice Y. Chan
MD, PhD
Pediatric allergist, immunologist and rheumatologist -
Morton J. Cowan
MD
Pediatric immunologist and bone marrow transplant specialist -
Jasmeen S. Dara
MD, MS
Pediatric immunologist and allergist -
Morna J. Dorsey
MD, MMS
Pediatric immunologist and allergist -
Jennifer M. Puck
MD
Pediatric immunologist -
Lauren Sanchez
MD
Pediatric immunologist and allergist -
Diane Wara
MD
Pediatric immunologist -
Xin-Hua Chen
LCSW, MSW
Social worker -
Mica Muskat
PNP
Pediatric nurse practitioner
Awards & recognition
-
Ranked among the nation's best in 11 specialties
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Support services
Clinical trials
Autologous Gene Therapy for Artemis-Deficient SCID
Patient survival status and (if applicable) cause of death will be recorded to assess overall survival.
Recruiting
More about this studyA Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
Safety will be evaluated based on incidence and severity of Adverse Events, Serious Adverse Events and laboratory assessments.
Recruiting
More about this studyOur research initiatives
Translation, please